These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 30039724

  • 1. A case of transthyretin amyloidosis with myopathy, neuropathy, and cardiomyopathy resulting from an exceedingly rare mutation transthyretin Ala120Ser (c.418G > T, p.Ala140Ser).
    Patel K, Tagoe C, Bieri P, Weidenheim K, Tauras JM.
    Amyloid; 2018 Sep; 25(3):211-212. PubMed ID: 30039724
    [No Abstract] [Full Text] [Related]

  • 2. Late-onset and fast progressive neuropathy and cardiomyopathy in Val32Ala transthyretin gene mutation.
    Cazzato D, Dalla Bella E, Saveri P, Taroni F, Marucci G, Lauria G.
    Neurol Sci; 2019 Jun; 40(6):1267-1269. PubMed ID: 30685801
    [Abstract] [Full Text] [Related]

  • 3. A case of hereditary amyloidosis transthyretin variant Met 30 with amyloid cardiomyopathy, less polyneuropathy, and the presence of giant cells.
    Nakamura Y, Yutani C, Nakazato M, Date Y, Baba T, Goto Y.
    Pathol Int; 1999 Oct; 49(10):898-902. PubMed ID: 10571824
    [Abstract] [Full Text] [Related]

  • 4. Transthyretin-related hereditary amyloid polyneuropathy presenting with large fibre involvement and cardiomyopathy.
    Cruz S, Cortes-Vicente E, Illa I, Rojas-Garcia R.
    Amyloid; 2016 Oct; 23(1):64-5. PubMed ID: 26806028
    [No Abstract] [Full Text] [Related]

  • 5. Epidemiological and clinical characteristics of persons with transthyretin hereditary amyloid polyneuropathy: a global synthesis of 532 cases.
    Cruz MW, Schmidt H, Botteman MF, Carter JA, Chopra AS, Stewart M, Hopps M, Fallet S, Amass L.
    Amyloid; 2017 Mar; 24(sup1):109-110. PubMed ID: 28434345
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of transthyretin cardiomyopathy with a TTR-specific antisense oligonucleotide (IONIS-TTRRx).
    Benson MD, Ackermann EJ, Monia BP.
    Amyloid; 2017 Mar; 24(sup1):134-135. PubMed ID: 28434337
    [No Abstract] [Full Text] [Related]

  • 7. Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation.
    Tini G, Vianello PF, Gemelli C, Grandis M, Canepa M.
    J Cardiovasc Transl Res; 2019 Dec; 12(6):514-516. PubMed ID: 30604309
    [Abstract] [Full Text] [Related]

  • 8. Hereditary amyloid neuropathy by transthyretin Val107 mutation in a patient of African origin.
    Cassereau J, Lavigne C, Letournel F, Ghali A, Verny C, Dubas F, Devière F, Nicolas G.
    J Peripher Nerv Syst; 2008 Sep; 13(3):251-4. PubMed ID: 18844793
    [No Abstract] [Full Text] [Related]

  • 9. Effect of doxycycline and ursodeoxycholic acid on transthyretin amyloidosis.
    Wixner J, Pilebro B, Lundgren HE, Olsson M, Anan I.
    Amyloid; 2017 Mar; 24(sup1):78-79. PubMed ID: 28042702
    [No Abstract] [Full Text] [Related]

  • 10. Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant.
    García-Herola A, Prieto M, Pascual S, Berenguer M, López-Viedma B, Mir J, Vilchez JJ, Berenguer J.
    Liver Transpl Surg; 1999 May; 5(3):246-8. PubMed ID: 10226117
    [Abstract] [Full Text] [Related]

  • 11. Cardiac Involvement in a Patient Cohort With Val30Met Mutation Transthyretin Amyloidosis.
    Ripoll-Vera T, Buades J, Cisneros E, Gómez Y, Núñez J, Raya M.
    Rev Esp Cardiol (Engl Ed); 2019 Jan; 72(1):92-94. PubMed ID: 29223374
    [No Abstract] [Full Text] [Related]

  • 12. Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis.
    Brown EE, Lee YZJ, Halushka MK, Steenbergen C, Johnson NM, Almansa J, Tedford RJ, Cingolani O, Russell SD, Sharma K, Judge DP.
    Amyloid; 2017 Jun; 24(2):92-95. PubMed ID: 28494620
    [Abstract] [Full Text] [Related]

  • 13. Hereditary ATTR Amyloidosis with Cardiomyopathy Caused by the Novel Variant Transthyretin Y114S (p.Y134S).
    Nakase T, Yamashita T, Matsuo Y, Nomura T, Sasada K, Masuda T, Misumi Y, Takamatsu K, Oda S, Furukawa Y, Obayashi K, Matsui H, Ando Y, Ueda M.
    Intern Med; 2019 Sep 15; 58(18):2695-2698. PubMed ID: 31178489
    [Abstract] [Full Text] [Related]

  • 14. Atrial impairment in transthyretin cardiac amyloidosis: an early marker of cardiac involvement and a prognostic factor.
    Di Bella G, Minutoli F.
    Amyloid; 2018 Jun 15; 25(2):135. PubMed ID: 29523040
    [No Abstract] [Full Text] [Related]

  • 15. Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg.
    Watanabe T, Obayashi K, Misumi Y, Tasaki M, Shinriki S, Ando T, Akagami T, Ueda M, Yamashita T, Hirotani S, Ando Y.
    Amyloid; 2017 Mar 15; 24(sup1):119. PubMed ID: 28434332
    [No Abstract] [Full Text] [Related]

  • 16. Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy.
    Masuda T, Ueda M, Suenaga G, Misumi Y, Tasaki M, Izaki A, Yanagisawa Y, Inoue Y, Motokawa H, Matsumoto S, Mizukami M, Arimura A, Deguchi T, Nishio Y, Yamashita T, Inomata Y, Obayashi K, Ando Y.
    Neurology; 2017 Jun 06; 88(23):2192-2197. PubMed ID: 28490654
    [Abstract] [Full Text] [Related]

  • 17. Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly and Val30Met).
    Koike H, Nakamura T, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Yasuda T, Mukai E, Date Y, Shiomi K, Nakazato M, Katsuno M, Sobue G.
    Amyloid; 2019 Jun 06; 26(sup1):24-25. PubMed ID: 31343348
    [No Abstract] [Full Text] [Related]

  • 18. A genealogical and clinical study of the phenotypical variation within the Swedish transthyretin His88Arg (p. His108Arg) amyloidosis family.
    Hellman U, Lundgren HE, Westermark P, Stafberg C, Nahi H, Tachlinski S, Guggi M, Flogegård M, Hamid M, Escher SA, Suhr OB.
    Eur J Med Genet; 2015 Apr 06; 58(4):211-5. PubMed ID: 25721874
    [Abstract] [Full Text] [Related]

  • 19. Transthyretin Glu54Leu - an unknown mutation within the Swedish population associated with amyloid cardiomyopathy and a unique fibril type.
    Hellman U, Lång K, Ihse E, Jonasson J, Olsson M, Lundgren HE, Pilebro B, Westermark P, Wixner J, Anan I.
    Scand J Clin Lab Invest; 2019 Oct 06; 79(6):372-376. PubMed ID: 31169435
    [Abstract] [Full Text] [Related]

  • 20. Response: Atrial impairment in transthyretin cardiac amyloidosis: an early marker of cardiac involvement and a prognostic factor.
    Henein MY, Lindqvist P.
    Amyloid; 2018 Jun 06; 25(2):136. PubMed ID: 29529882
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.